Login

MEDAMI 2022 - Multimodality molecular neuro-imaging: clinical and technical state-of-the-art

4–7 Sept 2022
Europe/Zurich timezone

Session

Clinical/Accessibilty and data sharing

Session 10
7 Sept 2022, 10:30

Conveners

Clinical/Accessibilty and data sharing

  • Haemisch York (Varex Imaging)

Presentation materials

There are no materials yet.

  1. 43. The PETITION project – Image reconstruction software using only emission data for full and open ring PET scanners
    Marina Béguin
    07/09/2022, 10:30
    Other techniques and analysis
    Oral

    The PETITION (PET for InTensive Care units and Innovative protON therapy) collaboration is currently developing two compact brain Positron Emission Tomography (PET) scanners with a focus on new clinical applications. The first device (ICU device) is a mobile scanner intended to scan deeply sedated, critically-ill patients with sepsis directly in the Intensive Care Units (ICU). The second...

    Go to contribution page
  2. 45. Metabolic brain networks in neurodegenerative dementias
    Matej Perovnik (University Medical Centre Ljubljana)
    07/09/2022, 10:45
    AI and large data sets
    Oral

    Neurodegenerative dementias are a group of slowly progressing neurological disorders with the most common being dementia due to Alzheimer’s disease (AD) and dementia with Lewy bodies (DLB). Despite different main pathology and symptoms, there can be a substantial overlap in concomitant pathology and clinical presentation and misdiagnosis is not uncommon even at specialized dementia clinics....

    Go to contribution page
  3. 42. The effect of image resolution and identification group size on the diagnostic performance of Alzheimer’s disease related metabolic pattern
    Eva Rebec (Faculty of Mathematics and Physics, University of Ljubljana), Dr Petra Tomše (University Medical Centre Ljubljana)
    07/09/2022, 11:00
    AI and large data sets
    Oral

    Alzheimer’s disease (AD) is the most common neurodegenerative brain disorder and AD-related metabolic pattern (ADRP) is its biomarker that has shown promising results in several studies. One of the obstacles towards successful translation to the clinic is limited evidence on its diagnostic performance with incoherent imaging data - for example different image resolution and identification...

    Go to contribution page
  4. 47. Insight into multivariate metabolic brain network structure: connectivity of Creutzfeldt-Jakob’s disease and frontotemporal dementia-related pattern
    Tomaž Rus
    07/09/2022, 11:15
    AI and large data sets
    Oral

    Introduction: Multivariate metabolic brain patterns obtained by SSM/PCA analysis of [18F]FDG-PET scans represent discrete functional brain networks. They were identified and validated in most neurodegenerative dementias and are routinely used in clinical practice. However, the internal structure of these networks remains unknown. In this study, we explored metabolic connectivity with graph...

    Go to contribution page
  5. 34. Availability and affordability of PET tracers, the challenges and opportunities in developing countries
    Ibrahim ElSayed
    07/09/2022, 11:30
    Accessibilty and data sharing
    Invited Virtual

    The PET-CT technology and its continuous developments are widely spread all over the world, however the distribution of the cyclotrons and the availability and affordability of its tracers is not well organized among the developing countries and varies greatly from country to another and consequently will affect the number of installed PET-CT scanners. According to the IAEA database the number...

    Go to contribution page
  6. 74. Round Table - The impact of AI methodology on research and clinical application
    07/09/2022, 12:00
    Invited

    The impact of AI methodology vs dedicated scanners (or a combination of both) on research and clinical application

    Go to contribution page
Building timetable...